effect of Spirulina in nonalcoholic fatty liver disease

Not Applicable

Recruiting

• Conditions: onalcoholic Fatty Liver Disease.; Other specified inflammatory liver diseases; K75.8

• Registration Number: IRCT20110510006431N5
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Age =18 years old, AST?>?38, ALT?>?40, Steatohepatitis grade 1,2 or 3 according to Ultrasound report, Having a history of alcohol consumption of less than 10 gram per day in women and less than 20 gram per day in men, Absence of other acute and chronic diseases and liver disorders (hepatitis B, C, etc.), biliary disease, known autoimmune diseases, cancer and inherited disorders affecting liver condition (storage disease of iron, and copper. ..), Hypertension, cardiovascular diseases, lung disease and kidney disease, cirrhosis, and celiac disease, Absence of pregnancy or lactation, Athletes or hospitalization, No consumption medications such as metformin, vitamin E and Ursodeoxycholic Acid (UDCA), No consumption hepatotoxic drugs such as phenytoin, tamoxifen and lithium, and corticosteroids and methotrexate, No consumption medications or antibiotics over a week during the study period or before entering it, No history of weight loss surgery in during year during, weight loss program during past 3-month, No history of hypothyroidism, Cushing's syndrome, and diabetes, Lack of gall bladder disease

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified